Organogenesis Holdings Inc (FRA:2PQ)
€ 2.52 -0.04 (-1.56%) Market Cap: 336.21 Mil Enterprise Value: 356.79 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 74/100

Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 05:15PM GMT
Release Date Price: €12.2 (-10.95%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining today for the Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analysts here. From Organogenesis, I'm delighted to have President and CEO Gary Gillheeney and CFO David Francisco here with us today. Just before we get started, a disclaimer. For important disclosures, please see the morganstanley.com research disclosures website. If you have any questions, please reach out to your Morgan Stanley sales rep. And if you are tuning into the webcast, feel free to send in any questions, and we'll try to read those into the conversation as well.

And with that, Gary and David, thank you so much for your time here today. Really appreciate your participation in the conference again this year. So, looking forward to the discussion.

Gary S. Gillheeney
Organogenesis Holdings Inc. - President, CEO & Director

Well, thank you. We appreciate the opportunity, Drew.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot